Latest filings (excl ownership)
8-K
Other Events
23 Apr 24
EFFECT
Notice of effectiveness
22 Apr 24
8-K
Material Modifications to Rights of Security Holders
19 Apr 24
S-3/A
Shelf registration (amended)
17 Apr 24
8-K
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
17 Apr 24
10-K
2023 FY
Annual report
16 Apr 24
8-K
Submission of Matters to a Vote of Security Holders
10 Apr 24
8-K
Entry into a Material Definitive Agreement
8 Apr 24
NT 10-K
Notice of late annual filing
2 Apr 24
DEF 14A
Definitive proxy
12 Mar 24
8-K
Departure of Directors or Certain Officers
16 Feb 24
S-3
Shelf registration
14 Feb 24
PRE 14A
Preliminary proxy
12 Feb 24
8-K
Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives
31 Jan 24
8-K
Entry into a Material Definitive Agreement
25 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
22 Jan 24
8-K
Entry into a Material Definitive Agreement
17 Jan 24
424B5
Prospectus supplement for primary offering
16 Jan 24
8-K
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
9 Nov 23
424B5
Prospectus supplement for primary offering
9 Nov 23
10-Q
2023 Q3
Quarterly report
9 Nov 23
8-K
Other Events
26 Sep 23
S-8
Registration of securities for employees
30 Aug 23
8-K
Departure of Directors or Certain Officers
28 Aug 23
8-K
Departure of Directors or Certain Officers
16 Aug 23
8-K
Windtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business Updates
7 Aug 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
ARS
2022 FY
Annual report to shareholders
29 Jun 23
DEFA14A
Additional proxy soliciting materials
29 Jun 23
DEFA14A
Additional proxy soliciting materials
29 Jun 23
DEF 14A
Definitive proxy
29 Jun 23
8-K
Departure of Directors or Certain Officers
27 Jun 23
8-K
Other Events
14 Jun 23
EFFECT
Notice of effectiveness
31 May 23
CORRESP
Correspondence with SEC
25 May 23
UPLOAD
Letter from SEC
24 May 23
S-8
Registration of securities for employees
19 May 23
S-3
Shelf registration
19 May 23
8-K
Windtree Therapeutics Reports First Quarter 2023 Financial Results and Provides Key Business Updates
15 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
Latest ownership filings
SC 13G/A
Lincoln Park Capital Fund, LLC
14 Feb 24
SC 13G/A
Lind Global Fund II LP
13 Feb 24
SC 13G
Flynn James E
1 Feb 24
SC 13G
Duvvuri Krishna
13 Nov 23
4
Craig Fraser
28 Sep 23
4
Craig Fraser
27 Sep 23
3
Jamie McAndrew
5 Sep 23
4
Daniel E. Geffken
29 Aug 23
4
Leslie J. Williams
25 Aug 23
4
Mark Strobeck
25 Aug 23
4
ROBERT A SCOTT
25 Aug 23
4
Steven Simonson
25 Aug 23
4
Eric Curtis
25 Aug 23
4
Craig Fraser
25 Aug 23
3
Mark Strobeck
28 Jun 23
SC 13D/A
Huang James
17 May 23
SC 13G
Lind Global Fund II LP
28 Apr 23
4
Craig Fraser
27 Apr 23
4
Craig Fraser
26 Apr 23
SC 13G
Lincoln Park Capital Fund, LLC
24 Apr 23
SC 13D/A
Huang James
19 Apr 23
4
Steven Simonson
2 Mar 23
4
Craig Fraser
2 Mar 23
4
Eric Curtis
2 Mar 23
4
DIANE CARMAN
2 Mar 23
SC 13D/A
Huang James
23 Feb 23
4
James Huang
23 Feb 23
SC 13D/A
Huang James
9 Feb 23
3
John A Tattory
3 Feb 23
4
Craig Fraser
27 Jul 22
4
John P. Hamill
26 Jul 22
4
Craig Fraser
26 Jul 22
4
Craig Fraser
5 Jul 22
4
Craig Fraser
30 Jun 22
4
Leslie J. Williams
9 Jun 22
4
ROBERT A SCOTT
9 Jun 22
4
James Huang
9 Jun 22
4
Daniel E. Geffken
9 Jun 22
4
Craig Fraser
17 Mar 22
4
Steven Simonson
15 Mar 22